Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09

Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. J Clin Oncol (2014) 2.21

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol (2008) 2.04

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev (2011) 1.94

Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79

A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst (2012) 1.74

Diabetes and pancreatic cancer. Mol Carcinog (2012) 1.71

Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst (2009) 1.71

Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev (2009) 1.70

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res (2009) 1.67

Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut (2012) 1.66

New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54

Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol (2006) 1.31

The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29

Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control (2010) 1.29

Obesity adversely affects survival in pancreatic cancer patients. Cancer (2010) 1.28

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst (2009) 1.27

New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res (2010) 1.25

Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia (2008) 1.24

Obesity and cancer. BMJ (2007) 1.23

Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J Gastroenterol Hepatol (2012) 1.23

Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21

Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis (2012) 1.20

Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18

High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One (2011) 1.17

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17

Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila) (2011) 1.16

Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas (2013) 1.15

Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol (2008) 1.15

Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control (2008) 1.15

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med (2011) 1.12

Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol (2013) 1.08

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08

Convergence of obesity and high glycemic diet on compounding diabetes and cardiovascular risks in modernizing China: an emerging public health dilemma. Global Health (2008) 1.06

Role of bacterial infections in pancreatic cancer. Carcinogenesis (2013) 1.06

Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) (2009) 1.06

Diabetes and risk of cancer. ISRN Oncol (2013) 1.06

Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr (2008) 1.05

Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas (2013) 1.05

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. Br J Cancer (2015) 1.04

Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03

Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr (2013) 1.01

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer (2007) 1.01

A prospective study of physical activity and the risk of pancreatic cancer among women (United States). BMC Cancer (2008) 1.01

Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer (2009) 1.00

Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res (2011) 0.99

Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. J Gastrointest Cancer (2013) 0.97

Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev (2011) 0.96

Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol (2010) 0.95

Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol Biomarkers Prev (2009) 0.94

Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control (2009) 0.93

A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors. Int J Endocrinol (2013) 0.93

Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol (2014) 0.92

Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium. Eur J Cancer Prev (2013) 0.91

Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2009) 0.91

Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev (2010) 0.91

Vitamin D and pancreatic cancer. Ann Epidemiol (2008) 0.90

Physical activity and pancreatic cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev (2008) 0.90

Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer (2014) 0.89

Risk factors and therapeutic targets in pancreatic cancer. Front Oncol (2013) 0.88

Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ (2015) 0.88

Metabolic syndrome and risk of death from cancers of the digestive system. Metabolism (2010) 0.87

Is dietary fat, vitamin D, or folate associated with pancreatic cancer? Mol Carcinog (2012) 0.86

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Carcinogenesis (2011) 0.86

Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer (2013) 0.86

Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2012) 0.85

Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol (2014) 0.84

Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. Am J Epidemiol (2015) 0.83

Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer (2008) 0.83

Warburg effect regulated by amphiregulin in the development of colorectal cancer. Cancer Med (2015) 0.83

The pathobiological impact of cigarette smoke on pancreatic cancer development (review). Int J Oncol (2012) 0.82

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma. PLoS One (2016) 0.82

Nut consumption and risk of pancreatic cancer in women. Br J Cancer (2013) 0.81

Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells. PLoS One (2014) 0.81

A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol (2009) 0.80

Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. Am J Clin Nutr (2011) 0.80

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol (2015) 0.79

Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan. World J Gastroenterol (2014) 0.79

Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers. Cancer Causes Control (2008) 0.79

Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer. Int J Mol Epidemiol Genet (2014) 0.79

Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells. Oncogene (2015) 0.78

Serum glucose and risk of cancer: a meta-analysis. BMC Cancer (2014) 0.78

The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas (2015) 0.78

Vitamin d and pancreatic cancer-an update. Cancers (Basel) (2011) 0.78

Vitamin D and GI cancers: shedding some light on dark diseases. Ann Transl Med (2014) 0.78

Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1. Am J Physiol Cell Physiol (2015) 0.78

Review of screening for pancreatic cancer in high risk individuals. World J Gastroenterol (2011) 0.78

Pancreatic cancer in Canada: incidence and mortality trends from 1992 to 2005. Can J Gastroenterol (2009) 0.78

Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota. Pancreas (2014) 0.78

Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.77

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res (2016) 0.77

Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma. Oncol Lett (2012) 0.77

The relationship between glucose metabolism disorders and malignant thyroid disease. Int J Clin Oncol (2012) 0.76

Pancreatic cancer in chronic pancreatitis. Indian J Surg Oncol (2015) 0.76

Glycemic index, glycemic load, and the risk of pancreatic cancer among postmenopausal women in the women's health initiative observational study and clinical trial. Cancer Causes Control (2010) 0.76

Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: A veteran administration registry study. SAGE Open Med (2016) 0.76

Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol (2015) 0.75

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology (2006) 8.83

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology (2012) 7.22

Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med (2009) 6.42

Prevalence of oral HPV infection in the United States, 2009-2010. JAMA (2012) 6.02

Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev (2007) 6.00

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89

Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med (2002) 4.87

Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

Tissue-resident macrophages. Nat Immunol (2013) 4.09

Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93

Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69

Eating out in America, 1987-2000: trends and nutritional correlates. Prev Med (2004) 3.55

A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol (2003) 3.36

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24

High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group. Am J Clin Nutr (2010) 3.22

Methods of calculating deaths attributable to obesity. Am J Epidemiol (2004) 3.15

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med (2009) 3.12

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89

Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87

Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87

Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2006) 2.64

Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol (2014) 2.62

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62

Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60

Evaluation of the American Stop Smoking Intervention Study (ASSIST): a report of outcomes. J Natl Cancer Inst (2003) 2.54

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res (2006) 2.53

Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med (2007) 2.52

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA (2003) 2.50

Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol (2006) 2.48

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst (2006) 2.48

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48

A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res (2009) 2.48

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971-1975 to NHANES 1999-2002. Am J Clin Nutr (2006) 2.40

The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40